A Comparative Pharmaceutico-Analytical Study And Clinical Efficacy Of Raktamitrarka W.S.R. To Pandu Roga (Anaemia)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Change in Quantity of Haemoglobin
研究概览
简要总结
This study is A Comparative Pharmaceutico - Analytical Study And Clinical Efficacy of Raktamitrarka W.S.R. To Pandu Roga ( Anaemia). There will be 2 groups in the study, In Group A randomly selected and clinically diagnosed 30 patients of Pandu roga whose Hb gm % will be of 06 to 10 gm % . Group A will be given Raktamitrarka prepared as per classical method and 30 patients of Group B randomly selected and clinically diagnosed will be given Raktamitrarka prepared by contemporary method.
Trial will be conduct for a period of 2 months. Follow up of the case will be after every 15 days that is 4 times during treatment. Final assessment will be done after completion of 2 months course on the basis of subjective, objective and laboratoral assessment.
The data will be analyzed scientifically and statistically.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Sign and symptoms of Anaemia.
- •Evidence of Anaemia by lab investigations.
- •Participates in age group of 18-70 years.
- •Patients with Anaemia between 06gm %-10gm % of Haemoglobin.
排除标准
- •Patients suffered with serious cardiac disorders like MI, Cardiac failure and Crisis Patients having life threatening disease.
- •Patient having major illness like IDDM, DM which is poorly controlled or newly diagnosed or is taking new therapy or recently adjusted therapy.
- •Patient having Carcinoma.
- •Pregnant lady.
- •Patient with severe Anaemia below 06 gm% of Haemoglobin.
- •Patient suffering with Thalassemia, Bone marrow disorders, autoimmune disorders and Iron toxicity.
- •Patient himself or herself wants to withdraw from the clinical trial.
结局指标
主要结局
Change in Quantity of Haemoglobin
时间窗: 60 days
次要结局
- Anemia scale will be assessed(15 days,30 days & 45 days)